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ABSTRACT 34 
Human bed bug infestations have dramatically increased worldwide since the mid-1990s. A 35 
similar phenomenon was also observed in Israel since 2005, when infestations were reported 36 
from all over the country. Two single nucleotide polymorphisms (V419L and L925I) in the bed 37 
bug voltage sensitive sodium channel confer kdr-type resistance to pyrethroids. Using 38 
quantitative sequencing (QS), the resistance allele frequencies of Israeli bed bug populations 39 
from across the country were determined. Genomic DNA was extracted from samples of 12 40 
populations of bed bugs collected from Israel and DNA fragments containing the V419L or 41 
L925I and I936F mutations sites were PCR amplified. The PCR products were analyzed by QS 42 
and the nucleotide signal ratios calculated and used to predict the resistance allele frequencies of 43 
the unknown populations. Results of the genetic analysis show that resistant nucleotide signals 44 
are highly correlated to resistance allele frequencies for both mutations. Ten of the 12 tested 45 
populations had 100% of the L925I mutation and 0% of the V419L mutation. One population 46 
was heterogeneous for the L925I mutation and had 0% of the V419L mutation and another 47 
population was heterozygous for the V419L mutation and had 100% of the L925I mutation. 48 
I936F occurred only at low levels. These results indicate that bed bugs in Israel are genetically 49 
resistant to pyrethroids. Thus, pyrethroids should only be used for bed bug management with 50 
caution using effective application and careful monitoring procedures. Additionally, new and 51 
novel-acting insecticides and non-chemical means of controlling bed bugs should be explored. 52 
 53 
 54 
 55 
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INTRODUCTION 75 
Cimex lectularius L., the common bed bug, is an obligatorily hematophagous 76 
ectoparasitic insect that feeds on a variety of warm blooded mammals including humans 77 
(Usinger 1966, Boase 2004, Thomas et al. 2004, Reinhardt and Siva-Jothy 2007, Tawatsin et al. 78 
2011, Zhu et al. 2010). C. lectularius is widely distributed throughout temperate parts of the 79 
globe, and poses serious economic, psychological, and physiological problems to humans. 80 
Effective monitoring and managing of bed bug populations and preventing or delaying 81 
development of insecticide resistance are keys to reducing and eliminating the ramifications that 82 
accompany their presence.  83 
Human reactions to C. lectularius bites are highly variable (Boase 2004, Thomas et al. 84 
2004, Wang et al. 2011). The initial bite of a bug is usually not felt. However, later the bite site 85 
itches, swells, burns, becomes inflamed or forms a weal and is very disturbing for the victim. 86 
There may be a central punctum at the site of the bite. Recurrent bites are often concentrated on 87 
the arms, legs and back, as well as on the face around the eyes. Lesions are frequently present in 88 
linear or clustered arrangements (Mumcuoglu, 2008). It is generally believed that bed bugs are 89 
not likely a vector for human disease (Blow et al. 2001, Boase 2004, Moore and Miller 2006, 90 
Reinhardt and Siva-Jothy 2007, Romero et al. 2007, Weeks et al. 2011, Doggett et al. 2012). 91 
Recently, Salazar et al. (2014) have shown that the common bed bug may be vector of 92 
Trypanosoma cruzi and could pose a risk for vector-borne transmission of Chagas disease. 93 
However, there is no evidence that the common bed bud actually transmits this pathogen in the 94 
field. 95 
C. lectularius was a well-known parasite in human dwellings throughout the world until 96 
the end of WWII. The prevalence of common bed bug infestations decreased dramatically in 97 
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developed countries until the 1980s, largely due to the introduction and widespread use of 98 
insecticides, such as DDT and malathion, and probably the improvement in housing conditions 99 
and hygiene (Usinger 1966, Reinhardt and Siva-Jothy 2007). Bed bug infestations increased 100 
dramatically after the mid-1990s in the United States, the United Kingdom, various other 101 
European countries (Koganemaru and Miller 2013), Australia, Brazil, Chile (Faundez and 102 
Carvajal 2014) and China (Wang et al. 2013).  103 
Infestations by the common bed bug were very common in what today is Israel until 104 
WWII (Kaufmann 1938, Dolev 2007). With the intensive use of DDT and lindane, the parasite 105 
became very rare and the few remaining pests were most probably those that became resistant to 106 
DDT (Levinson 1953, Cwilich et al. 1957, Gratz 1958, 1959, Busvine 1977, Mumcuoglu, 2008). 107 
During the years of 2006-2008, a 50-150% increase in the reported cases of infestations occurred 108 
in comparison to the period of 2001-2005. Bed bugs were mainly reported in hotels,  residences 109 
and prisons, as well as in industrial buildings (Mumcuoglu and Shalom 2010). The most 110 
commonly used insecticides during this time were pyrethroids, followed by organophosphorous 111 
and carbamate insecticides. Banning the use of organophosphates inside houses and work places, 112 
as well as increasing numbers of foreign workers and new immigrants from developing 113 
countries, were considered additional factors for the increased number of bed bug infestations. 114 
Bed bugs have proven to be very difficult pests to control, and insecticides have been 115 
used widely to control existing infestations (Thomas et al. 2004) and prevent reinfestations 116 
(Weeks et al. 2011). The selection of insecticide-resistant bed bugs is a significant contributing 117 
factor to their recent resurgence. Various strains of bed bugs from different geographical 118 
locations can have different resistance mechanisms (Yoon et al. 2008, Kilpinen et al. 2008, Zhu 119 
et al. 2013, Romero et al. 2009, Bai et al. 2011). 120 
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Bed bugs have demonstrated strong resistance to the pyrethroids (Seong et al. 2010), a 121 
class of insecticide that has been favored for bed bug control due to their high efficacy and low 122 
mammalian toxicity (Yoon et al. 2008). To date, bed bugs have developed multiple resistance 123 
mechanisms against pyrethroids, such as target site insensitivity due to mutations in the alpha-124 
subunit of the voltage-sensitive sodium channel (VSSC), increased xenobiotic metabolism, and 125 
decreased cuticular penetration (Yoon et al. 2008, Zhu et al. 2013, Adelman et al. 2011, 126 
Mamidala et al. 2011, Koganemaru et al. 2013, Dang et al., 2013). 127 
Pyrethroids target neuronal VSSCs of insects, which functions to generate and propagate 128 
action potentials in neurons (Zhu et al. 2010, Castèle and Catterall 2000). Pyrethroids selectively 129 
modify VSSC causing “repetitive discharge in motor and sensory axons and convulsive activity”, 130 
which leads to paralysis and death (Morin et al. 2002). Widespread use of DDT following World 131 
War II may have inadvertently selected bed bugs for pyrethrins/pyrethroid resistance as DDT 132 
and pyrethrins/pyrethroids share the same target site (Busvine 1958, Zhu et al. 2010, Moore and 133 
Miller 2006, Boase 2004, Yoon et al. 2008). Point mutations in the alpha subunit of the VSSC in 134 
insects confer resistance to pyrethroids through target site insensitivity, resulting in knockdown 135 
resistance (kdr) (Yoon et al. 2008). Kdr and kdr-type mutations have been identified in many 136 
insects and result in DDT resistance and cross-resistance to the pyrethrins/pyrethroids (Clark et 137 
al. 2013).  138 
Two mutations, a valine to leucine (V419L) and a leucine to isoleucine (L925I), have 139 
been identified by Yoon et al. (2008) in the highly deltamethrin-resistant common bed bug 140 
population (NY-BB), which conferred kdr-type resistance to pyrethroids. Both of these 141 
mutations result from single nucleotide polymorphisms (SNPs: GTCCTC and CTTATT for 142 
V419L and L925I, respectively) in the alpha subunit gene of the common bed bug VSSC 143 
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(Clvssc). A novel mutation I936F has also been identified in a single d-allethrin-resistant 144 
common bed bug population from Adelaide, Australia, but it appears to give only low levels of 145 
resistance and has not been validated as a kdr-type mutation functionally (Dang et al. 2014).  146 
Using this information, a quantitative sequencing (QS) protocol was developed to 147 
establish a population-based genotyping method as a molecular monitoring tool to predict the kdr 148 
allele frequencies in common bed bug populations (Seong et al. 2010). The kdr allele frequencies 149 
in different bed bug populations calculated by QS correlated well with filter contact vial bioassay 150 
data, confirming the role of the two mutations in pyrethroid resistance (Seong et al. 2010). 151 
Similar approaches based on these initial findings have been used widely to establish the role of 152 
these two mutation in pyrethroid resistance in many common bed bug populations worldwide 153 
(Zhu et al. 2010, Tawatsin et al. 2011, Durand et al. 2012, Tawatsin et al. 2013, Dang et al. 154 
2014). 155 
The purpose of this study was to predict the resistance allele frequencies of kdr-type 156 
mutations in common bed bug populations collected from 12 locations across Israel. This 157 
information is critical for those attempting to manage bed bug infestations in Israel, including 158 
homeowners and pest management professionals, at a time when current approaches are failing 159 
and infestations are increasing. Prior testing in other countries has shown that the frequencies of 160 
kdr-type alleles are highly correlated to pyrethroid resistance (Yoon et al. 2008, Seong et al. 161 
2010). Therefore, we hypothesize that the same two kdr-like mutations found in pyrethroid-162 
resistant bed bugs elsewhere (V419L and L925I) will also be found at high frequencies in the 163 
Israeli populations. Additionally, previous information has identified that the L925I mutation is 164 
particularly important in conferring neuronal insensitivity and pyrethroid resistance in bed bugs 165 
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(Yoon et al. 2008, Seong et al. 2010, Zhu et al. 2010). This study aims to contribute additional 166 
information towards validating or rejecting that hypothesis.  167 
 168 
MATERIALS AND METHODS 169 
Collection of common bed bug samples  170 
Bed bugs were collected by pest management professionals in Israel prior to treating the 171 
infested area with insecticide. The 12 collection sites were five apartments, three one-family 172 
houses, two hotels and two industrial buildings. Each population came from a different location 173 
in Israel (Table 1). Bed bugs (8-12 per location) were individually removed from their normal 174 
habitats, including but not limited to beds, wall carpets and frames and stored in 70% ethanol 175 
prior to processing. Bed bugs were collected between February 2011 and April 2012 and sent to 176 
the Pesticide Toxicology Laboratory, University of Massachusetts-Amherst, for genotyping 177 
analysis by QS. 178 
 179 
 180 
Sample selection for DNA extraction 181 
 All stored bed bugs from a common collection site/population were washed by removing 182 
the 70% ethanol and placing them into a 1.5 mL tube with 1 ml DNase free, double-distilled, 183 
H2O (ddH2O) and gently mixing the tubes by hand shaking. After 1-2 min, the wash solution was 184 
removed using a pipette. For each population, a single test sample, labeled BBM1 to BBM12, 185 
was prepared by first separating the different developmental stages. Life stages were determined 186 
by visual inspection according to Boase (2004) and Thomas et al. (2004). A single life stage (the 187 
largest and most abundant in the population) was selected as the test sample while all other bed 188 
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bugs were recombined and stored in 95% ethanol at -20°C. All test samples had multiple bed 189 
bugs of the same life stage (Table 2).  190 
Genomic DNA extraction  191 
Genomic DNA (gDNA) was extracted from the 12 test samples (BBM1-12) using the 192 
DNeasy Blood and Tissue Kit (Qiagen, Valencia, CA) following the manufacturer’s instructions. 193 
Briefly, all bed bugs in a test sample were placed into 2 mL micro-centrifuge tubes containing 194 
180 µL Buffer ATL, 0.9 µL reagent DX and five stainless steel grinding balls (0.25 g, SPEX 195 
Sample Prep, Metuchen, NJ) and homogenized in an automated homogenizer (Geno Grinder 196 
2010, SPEX Sample Prep, Metuchen, NJ) at 1250 strokes per min for 1 min. Proteinase K (20 197 
µL) was added to the tube and incubated for 3-24 h at 56°C. Following incubation, the lysate was 198 
transferred to a 1.5 mL tube with 100% ethanol (200 µL) and Buffer AL (200 µL) and vortexed. 199 
The sample was transferred to a DNeasy Mini spin column (Qiagen), and centrifuged for 30 s at 200 
6000g. The flow through was discarded and the column placed into a new collection tube before 201 
washing with 500 µL buffer AW1, followed by 500 µL buffer AW2 with centrifuging for 30 s at 202 
20,000g at each wash. The column was dried by centrifugation for 3 min at 20,000g before DNA 203 
elution. The column was placed into a new collection tube and incubated for 1 min with 50 µL 204 
buffer AE and centrifuged for 1 min at 6,000g to elute the DNA. This step was repeated to 205 
maximize total DNA yield.  206 
 Quantification of gDNA 207 
1 µl of extracted gDNA from a single test sample was applied to a NanoDrop ND 8000 208 
UV-Vis spectrophotometer (NanoDrop Technologies, Wilmington, DE), absorbance at 260 nm 209 
determined and used to calculate the DNA concentration in ng of DNA µL
-1
 using a modified 210 
Beer-Lambert equation. DNA purity was also determined by the ratio between absorbencies at 211 
Page 9 of 37
https://mc.manuscriptcentral.com/medent
Manuscripts submitted to Journal of Medical Entomology
10 
 
260 and 280 nm, with ratios between 1.5 and 1.8 indicative of pure samples. Samples were 212 
diluted to a concentration of 10 ng/µL and stored at -20°C. 213 
PCR amplification of gDNA 214 
15 µL of a master mix (12 µL ddH2O, 5 µL 5X Advantage HD Buffer, 1.75 µL 2.857 215 
mM dNTP mixture, 0.25 µL Advantage HD Polymerase and 1 µL of a 10 mM solution 216 
containing the forward and reverse primers for either V419L or L925I and I936F, Table 3) were 217 
mixed with 5 µL of template DNA (10 ng/µL) and placed onto an Eppendorf Mastercycler Pro 218 
(Hamburg, Germany) thermal cycler operated using the following parameters: 1 cycle at 95.0°C 219 
for 1 min; by 35 cycles of: 30 s at 95.0°C, 30 s at 61.0°C; and 1 min at 72.0°C. Gel 220 
electrophoresis (0.9% agarose) was used to verify quality and quantity of PCR DNA fragment 221 
amplification using ethidium bromide (1 µL of 10 mg/mL stock) staining to visualize PCR 222 
products under UV light. Where present, positive controls used an individual bed bug sample 223 
(BBS5) obtained from a laboratory-reared bed bug colony (FL-BB, Yoon et al, 2008). Negative 224 
controls for the PCR reaction used ddH20 as template, and in all cases no band was present after 225 
PCR amplification. This confirms that all reagents were free from gDNA contamination. 226 
PCR product purification:  227 
The QIAquick PCR Purification Kit (Qiagen) was used for PCR product purification 228 
following the manufacturer’s instructions. Briefly, 5 volumes of buffer PB were added to 1 229 
volume PCR product, mixed with 10 µL of 3M sodium acetate buffer, transferred to a QIAquick 230 
spin column placed in a 2 mL collection tube and centrifuged for 30 s at 20,000g. The column 231 
was first washed with 750 µL guanidine HCl (30 s) and then with 750 µL buffer PE (30 s). After 232 
drying by centrifugation, DNA was eluted into a 1.5 mL tube by applying 50 µL and then 30 µL 233 
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of Buffer EB and centrifuging at 20,000g for 1 min. Gel electrophoresis (0.9% agarose) was used 234 
to verify quantity and quality of products as above. 235 
Standard curve for QS analysis 236 
The QS protocol developed by Seong et al. (2010) was followed and standard curves 237 
generated using the deltamethrin-resistant NYS-BB (Seong et al. 2010) and the insecticide-238 
susceptible FL-BB (Yoon et al. 2008) strains of bed bugs for both mutations. Resistant and 239 
susceptible nucleotide signal intensities for each mixture were determined from sequence 240 
chromatograms and used to calculate nucleotide signal ratios (NSR) ([resistant nucleotide signal] 241 
/ [resistant nucleotide signal + susceptible nucleotide signal]). Resulting nucleotide signal ratios 242 
were plotted against known resistant allele frequencies to generate standard curve equations as 243 
well as lower and upper prediction band equations (Fig. 1) using Sigma Plot 10.0 (Systat 244 
Software Inc., San Jose, CA). The standard curves were used to predict resistance allele 245 
frequencies for the 12 unknown Israeli BBM populations at the 95% confidence level (Seong et 246 
al. 2010). A standard curve for the I936F mutation was not generated as the NSR values were 247 
consistently low. 248 
 249 
Determination of unknown resistant allele frequencies  250 
Triplicates for each test sample (BBM1-12), containing 5 µL of a 5 µM sequencing 251 
primer solution (3VLQS for V419L and 5LIQS for L925I and I936F, Table 3), were mixed with 252 
10 µL of purified PCR product (Fig. 2) at a concentration of (1 ng/µL), loaded into a 96 well 253 
plate and sent to GeneWiz (South Plainfield, NJ) for sequencing. Sequence chromatograms were 254 
analyzed using Chromas lite software (Technelysium Pty Ltd., Tewantin, Australia) to determine 255 
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the nucleotide signal intensity at the respective mutation site (Fig. 3). NSR were calculated and 256 
used to predict resistance allele frequency from the Standard curves (Seong et al. 2010). 257 
 258 
RESULTS 259 
Standard curves for the V419L and L925I mutations were generated from known 260 
populations of deltamethrin-resistant and susceptible bed bugs (Fig. 1). The equation for the 261 
V419L and L925I standard curves were: Y = 3.6754(1-[0.7271]
 x
) and Y = 2.0146(1-[0.4914]
 x
), 262 
respectively, where Y is the resistance allele frequency. The curves show that the resistant and 263 
susceptible nucleotide signal intensities, which were used to determine the NRSs, were highly 264 
correlated to resistance allele frequencies with an R
2 
value of 0.998 and 0.996 for the V419L and 265 
L925I curves, respectively. The V419L curve had smaller 95% prediction bands than the L925I 266 
curve, which may be due to different efficiencies in the dideoxy nucleotide terminator 267 
incorporation between the resistant and susceptible nucleotides in the sequencing reaction 268 
(Korch and Drabkin 1999). 269 
 After extracting gDNA from the 12 Israeli bed bug populations, absorbencies of the 270 
eluents were determined spectrophotometrically to determine the concentration and purity. For 271 
each test sample, the DNA concentrations (ng/µL) and purity (A260/A280 values) were as 272 
follows: BBM1 (123, 1.8), BBM2 (53, 1.7), BBM3 (43, 1.9), BBM4 (13, 2.9), BBM5 (76, 2.1), 273 
BBM6 (41, 1.9), BBM7 (94, 2.0), BBM8 (72, 1.9), BBM9 (120, 1.9), BBM10 (78, 2.1), BBM11 274 
(120, 2.2), BBM12 (5.5, 2.2) All test samples yielded sufficient DNA (~10 ng/µL) of required 275 
purity for PCR amplification. 276 
 Two separate PCR reactions were performed on the 12 test sample eluents (BBM1-12) to 277 
amplify DNA fragments encompassing the V419L or L925I and I936F mutation sites within the 278 
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alpha subunit gene of Clvssc. The size and quality of the PCR products were determined by 279 
electrophoresis on a 0.9% agarose gel with ethidium bromide staining. The expected sizes of the 280 
V419L or L925I and I936F PCR products were 354 and 360 base pairs (bp), respectively.  281 
The PCR products were purified and subjected to electrophoresis (Fig. 2). Bands at the 282 
expected sizes for the V419L or the L925I and I936F mutations confirmed the presence of the 283 
alleles of interest, and a band was present in the positive control, while no band was present in 284 
the negative control. Purified PCR products were sent to GeneWiz for sequencing. These 285 
sequences were analyzed with the QS protocol to determine the presence or absence of the three 286 
point mutations in the 12 test samples.  287 
The resistance allele frequencies at the V419L mutation for all populations were 0.0 with 288 
the exception of BBM9, which was heterogeneous with a resistance allele frequency of 0.39 289 
(Table 4). The resistance allele frequency of 0.0 corresponds to a 0% incidence of the V419L 290 
resistant allele in 11 of the 12 test samples. The 0.39 resistance allele frequency associated with 291 
one of the 12 populations samples (BBM9) corresponds to a 39% presence of the resistant allele 292 
at this site.  293 
The resistance allele frequency for the L925I mutation was 1.0 (100% presence of the 294 
L925I-resistant allele, all bed bugs within a sample have the mutation) for 11 of the 12 295 
populations tested (Table 4). The exception was the BBM10 sample, which had a resistance 296 
allele frequency of 0.61 (61%), indicating that this population was heterogeneous for the L925I 297 
mutation. NSRs were likewise determined for the I936F mutation for all samples but only ranged 298 
from 0.06 to 0.22 with an average NRS of 0.09.  299 
 300 
DISCUSSION 301 
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 Previously published research has shown that genetic resistance to DDT and the 302 
pyrethroids in common bed bugs is conferred, in part, by the presence of one or both of the 303 
V419l and L925I mutations. The goal of this project was to build upon these initial findings and 304 
determine the kdr-type resistance allele frequencies using QS in 12 bed bug populations 305 
collected from Israel in order to characterize the level and extent of these mutations, which lead 306 
to nerve insensitivity, so that monitoring and management strategies can be put into place. 307 
Results of the DNA extraction show that the modified methods used are generally 308 
successful. For BBM1-12, the average DNA concentration was 69.8 ng/µL and only one sample 309 
(BBM12) was below the 10 ng/µL concentration prescribed for PCR. The low concentration of 310 
the BBM12 sample may partly be due to the low sample size and life stage used (n =2, third 311 
instars). BBM12 is the only sample of the original twelve that used third instars and additionally 312 
has a sample size less than or equal to all other samples. Nevertheless, the gDNA extractions, 313 
PCR amplification and purification protocols provided sufficient and suitable products for the 314 
QS analysis. 315 
 Results of the QS analysis provided useful information as to the state of kdr-based 316 
DDT/pyrethroid resistance in Israel bed bug populations. Eleven out of the 12 samples 317 
populations lacked the V419L mutation but all 12 populations had the L925I mutation. The only 318 
populations with differing genotypes were BBM9 and BBM10. BBM9 was heterogeneous in 319 
terms of the presence of the V419L mutation (RAF = 0.39) but was homogeneous L925I 320 
mutation (RAF = 1.0). BBM10 lacked the V419L mutation (RAF = 0.0) but was heterogeneous 321 
for the L925I mutation (RAF = 0.61). Overall, only the BBM10 population did not have a RAF 322 
of 1.0 for the L925I mutation. None of the 12 sampled populations had the I936F mutation at 323 
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either high or intermediate levels and this mutation appears to either play no role in the genetic 324 
resistance to the pyrethroids or only a minor role. 325 
 A 2010 study by Zhu et al. provides relevant information for comparison to our current 326 
results. These authors investigated kdr-type mutations in 93 bed bug populations from across the 327 
USA and separated the populations into the following four haplotypes based on their genotypes: 328 
A (neither mutation), B (L9251 but not V419L), C (both mutations), and D (V419L but not 329 
L9251). Of the 93 populations, haplotype B was the most common (44%), followed by C (39%), 330 
A (12%) and D (3%). These results are comparable with the current results from Israeli bed bug 331 
populations. Eleven out of the 12 populations tested in this study were haplotype B (BBM1-8 332 
and BBM10-12) (92%), the most common haplotype. BBM9 was haplotype C (8%), the next 333 
most common haplotype. None of the samples tested in this study were haplotype A (0%) or D 334 
(0%). The most compelling piece of information comparing the current study to the Zhu et al. 335 
(2010) study is the frequencies of the L925I versus V419L mutations. Haplotype B, while the 336 
most common haplotype in both of these studies, is overwhelming the most common in the 337 
Israeli populations (Fig. 4). Interestingly, while 36 of the 93 populations tested by Zhu et al. 338 
(2010) were haplotype C (39%), only one of the bed bug populations tested in this study showed 339 
this haplotype (8%). Most recently, Dang et al. (2014) have shown that that there are high 340 
frequencies of kdr-type mutations associated with Australian bed bug populations, indicating the 341 
kdr-based pyrethroid resistance is also widespread across Australia. As found in Israel and 342 
elsewhere, haplotype B was most prevalent, haplotypes A and C were rare and haplotype D was 343 
not detected in Australia. Interestingly, two strains maintained in the laboratory, ‘Moonee Ponds’ 344 
and ‘Darlinghurst II’, appear to be losing the V419L mutation and becoming predominately 345 
haplotype B over time. 346 
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 In 2008, Yoon et al. suggested that the L9251 “may play a critical role in deltamethrin 347 
resistance”, after finding a cloned VSSC plasmid containing only this mutation, while all others 348 
contained both the L926I and V419L mutations. Seong et al. (2010) tested common bed bugs 349 
collected from Yongsan, Korea in 1993, 2007, 2008, and 2009 for kdr-type resistance allele 350 
frequencies using similar methods as the ones used in this study. Their findings showed no 351 
mutation for bed bugs collected in 1993, full saturation at both mutation sites in 2007, partial 352 
resistance for L925I (86%) and V419L (8%) in 2008, and 100% resistance for L925I with 0% 353 
resistance for V419L in 2009. The authors asserted that the L925I mutation appears to have been 354 
selected more intensively then the V419L mutation. The results from the Israeli bed bug 355 
populations presented here support his notion and further suggest that a fitness disadvantage may 356 
be associated with the V419L mutation. 357 
 Based on the trend previously shown in genetic analysis of kdr-based resistance in bed 358 
bugs in the USA, selective pressure appears to cause bed bugs exposed to pyrethroids to select 359 
both mutations but over time the V419L mutation is lost, leaving only the L925I mutation in 360 
heavily selected populations. If the use of pyrethroids for controlling bed bugs continues in 361 
Israel, selective pressure will likely favor the L925I haplotype. The results of this current study 362 
show that this may have already begun in Israel as 11 out of the 12 populations are homozygous 363 
for the L925I mutation with very few bed bugs maintaining the V419L mutation.  364 
 365 
Conclusion 366 
 This paper aimed to elucidate the status of genetic resistance to pyrethroids in bed bug 367 
populations collected from Israel. Based on QS results, genetic testing showed that the majority 368 
of Israeli bed bugs examined in this study are resistant to pyrethroids by the kdr mechanism. 369 
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Continued use of pyrethroids on Israeli bed bugs will further select for a highly resistant 370 
populations. To effectively control these pests, alternative methods of treatments should be 371 
explored. 372 
   373 
 374 
 375 
 376 
 377 
 378 
 379 
 380 
 381 
 382 
 383 
 384 
 385 
 386 
 387 
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 555 
Table 1. Location and habitat of the 12 bed bug populations collected from Israel 556 
Population # Location Habitat 
1 Jerusalem Apartment 
2 Tel Aviv Apartment 
3 Kfar Sava Industrial Building 
4 Kfar Sava House 
5 Haifa Industrial Building 
6 Hadera Apartment 
7 Eilat Hotel 
8 Tel Aviv Hotel 
9 Netanya Apartment 
10 Nazareth House 
11 Rehovot Apartment 
12 Jerusalem House 
 557 
 558 
 559 
 560 
 561 
 562 
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Table 2. Sample sizes and life stages of the 12 tested QS samples from bed bug  563 
populations collected from Israel 564 
Population Sample Size Life Stage Used 
BBM1 4 Adult 
BBM2 2 Adult 
BBM3 3 Fourth instar 
BBM4 4 Fourth instar 
BBM5 6 Adult 
BBM6 10 Fourth instar 
BBM7 2 Adult 
BBM8 4 Adult 
BBM9 2 Adult 
BBM10 5 Fourth instar 
BBM11 3 Fourth instar 
BBM12 2 Third instar 
 565 
 566 
 567 
 568 
 569 
 570 
  571 
 572 
 573 
 574 
 575 
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Table 3. PCR and QS primers used for the amplification of DNA fragments containing  576 
the V419L or L929I and I936F mutations and for sequencing reactions 577 
Primer 
name 
Sequence  Purpose 
3’PCRVL 5’-CTGATGGAGATTTTGCCACTGATG-3’ VL sense PCR Primer 
5’PCRVL 5’-GTCCGTGGCACATGTTGTTCTTCA-3’ VL antisense PCR Primer 
3’PCRLI 5’-GGAGTTCGCCATCAGGGAATCTAT-3’ LI sense PCR Primer 
5’PCRLI 5’-GGTCTATCAGTTTTGAGGTCATTCAG-3’ LI antisense PCR Primer 
3’QSVL 5’-CCTCTTCAGCTTCTTCTTCTT-3’ VL sequencing primer 
5’QSLI 5’- GTGTTTAAGCTGGCTAAGTCATGGCC-3’ LI sequencing primer 
 578 
 579 
 580 
 581 
 582 
 583 
 584 
 585 
 586 
 587 
 588 
 589 
 590 
 591 
 592 
 593 
 594 
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Table 4. Nucleotide Signal Ratios (NSR) and Resistant Allele Frequencies (RAF) for bed 595 
bug samples. 596 
1
SD = Standard Deviation. 597 
 598 
 599 
 600 
 601 
 602 
 603 
 604 
 605 
 606 
 607 
 608 
 V419L L925I I936F 
Population 
Nucleotide 
Signals NSR 
 
RAF 
(SD
1
) 
Nucleotide 
Signals NSR 
 
RAF 
(SD
1
) 
Nucleotide 
Signals NSR 
 
Sus. Res. Sus. Res. Sus. Res. 
BBM1 599 0 0.0 0.0 0 548 1.0 1.0 1049 93 0.08 
BBM2 743 0 0.0 0.0 0 552 1.0 1.0 989 155 0.14 
BBM3 683 0 0.0 0.0 0 582 1.0 1.0 1064 109 0.09 
BBM4 516 0 0.0 0.0 0 513 1.0 1.0 979 271 0.22 
BBM5 664 0 0.0 0.0 0 549 1.0 1.0 1039 81 0.07 
BBM6 678 0 0.0 0.0 0 574 1.0 1.0 1082 156 0.13 
BBM7 577 0 0.0 0.0 0 564 1.0 1.0 1042 106 0.09 
BBM8 667 0 0.0 0.0 0 577 1.0 1.0 1046 62 0.06 
BBM9 402 226 0.36 
0.399 
(0.032) 
0 549 1.0 1.0 1093 95 0.08 
BBM10 811 0 0.0 0.0 340 354 0.51 
0.613 
(0.002) 
974 222 0.19 
BBM11 757 0 0.0 0.0 0 561 1.0 1.0 1057 114 0.10 
BBM12 749 0 0.0 0.0 0 555 1.0 1.0 1044 121 0.10 
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Figure Captions 609 
 610 
Fig. 1. Standard curves for V419L and L925I mutations. Resistant nucleotide signals from QS 611 
were plotted against corresponding resistant allele frequencies at the V419L (A) and L925I (B) 612 
mutations sites. Equations of the lines are listed above each graph. Black linear regression lines 613 
are shown with 95% confidence bands in red. Nucleotide signal ratios were calculated as 614 
follows: resistant nucleotide signal / [resistant nucleotide signal + susceptible nucleotide signal]. 615 
Fig. 2. Agarose gel (0.9%) electrophoresis of BBM V419L (A) and L925I purified PCR 616 
products. Lane numbers correspond to BBM test samples (i.e., 1, 2, 3 for BBM1, BBM2, BBM3 617 
etc.), a 100 basepair (bp) ladder (L, 100 – 1,200 bp, select marker sizes are indicated on left), 618 
positive control (+, BBS5 from prior experimentation), and a negative control (-, ddH2O). An 619 
asterisk (*) indicates the expected size of the respective PCR product and corresponds to the 620 
experimental bands indicating successful PCR of the target DNA fragment. PCR products were 621 
visualized under ultraviolet light using ethidium bromide staining. 622 
Fig. 3. Sequencing chromatograms showing differences between susceptible, mixed, and 623 
resistant nucleotide signals. On the left hand side, the VSSC amino acid substitution that results 624 
in a kdr mutation is indicated, and the corresponding base pair change is bolded and underlined. 625 
These same base pairs are indicated by an arrow in the chromatogram sequence, and its identity 626 
is boxed on the chromatogram base pair readout. “N” indicates that there is no sequence 627 
consensus, i.e. the population is mixed and contains both resistant and susceptible alleles.  628 
Fig. 4. Geographic distribution of kdr-type mutations in common bed bug populations collected 629 
from Israel. Pie charts show haplotype frequencies for the twelve bed bug populations tested. 630 
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Haplotypes: A (neither mutation, black), B (L925I only, white), C (both mutations, grey). 631 
Haplotype D (V419L only) is not represented in any population and is omitted.  632 
 633 
 634 
 635 
 636 
 637 
 638 
 639 
 640 
 641 
 642 
 643 
 644 
 645 
 646 
 647 
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Fig 1. 648 
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Fig 2. 670 
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Fig 3. 687 
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Fig 4. 703 
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Table 3. PCR and QS primers used for the amplification of DNA fragments containing  
the V419L or L929I and I936F mutations and for sequencing reactions 
Primer 
name 
Sequence  Purpose 
3’PCRVL 5’-CTGATGGAGATTTTGCCACTGATG-3’ VL sense PCR Primer 
5’PCRVL 5’-GTCCGTGGCACATGTTGTTCTTCA-3’ VL antisense PCR Primer 
3’PCRLI 5’-GGAGTTCGCCATCAGGGAATCTAT-3’ LI sense PCR Primer 
5’PCRLI 5’-GGTCTATCAGTTTTGAGGTCATTCAG-3’ LI antisense PCR Primer 
3’QSVL 5’-CCTCTTCAGCTTCTTCTTCTT-3’ VL sequencing primer 
5’QSLI 5’- GTGTTTAAGCTGGCTAAGTCATGGCC-3’ LI sequencing primer 
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Table 4. Nucleotide Signal Ratios (NSR) and Resistant Allele Frequencies (RAF) for bed 
bug samples. 
1
SD = Standard Deviation. 
 
 
 V419L L925I I936F 
Population 
Nucleotide 
Signals NSR 
 
RAF 
(SD
1
) 
Nucleotide 
Signals NSR 
 
RAF 
(SD
1
) 
Nucleotide 
Signals NSR 
 
Sus. Res. Sus. Res. Sus. Res. 
BBM1 599 0 0.0 0.0 0 548 1.0 1.0 1049 93 0.08 
BBM2 743 0 0.0 0.0 0 552 1.0 1.0 989 155 0.14 
BBM3 683 0 0.0 0.0 0 582 1.0 1.0 1064 109 0.09 
BBM4 516 0 0.0 0.0 0 513 1.0 1.0 979 271 0.22 
BBM5 664 0 0.0 0.0 0 549 1.0 1.0 1039 81 0.07 
BBM6 678 0 0.0 0.0 0 574 1.0 1.0 1082 156 0.13 
BBM7 577 0 0.0 0.0 0 564 1.0 1.0 1042 106 0.09 
BBM8 667 0 0.0 0.0 0 577 1.0 1.0 1046 62 0.06 
BBM9 402 226 0.36 
0.399 
(0.032) 
0 549 1.0 1.0 1093 95 0.08 
BBM10 811 0 0.0 0.0 340 354 0.51 
0.613 
(0.002) 
974 222 0.19 
BBM11 757 0 0.0 0.0 0 561 1.0 1.0 1057 114 0.10 
BBM12 749 0 0.0 0.0 0 555 1.0 1.0 1044 121 0.10 
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